Gaetano Bacci Selected Research

Drug Therapy (Chemotherapy)

07/2007	Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma.
06/2007	Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999.
02/2007	Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years.
02/2007	Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
12/2006	Second malignant neoplasm in patients with osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy.
07/2006	The role of surgical margins in treatment of Ewing's sarcoma family tumors: experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy.
06/2006	Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
03/2006	Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
01/2006	Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.
12/2005	Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
12/2005	Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
10/2005	Second malignancy in 597 patients with ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
09/2005	Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution.
01/2005	Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
01/2004	Role of surgery in local treatment of Ewing's sarcoma of the extremities in patients undergoing adjuvant and neoadjuvant chemotherapy.
11/2003	Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome.
08/2003	Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy.
07/2003	Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: implication for cell-based therapy in bone defect reconstruction.
07/2003	Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
06/2003	Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor.
04/2003	Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma.
03/2003	A comment and update on "Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival?".
01/2003	Effect of oral contraceptive on ovarian function in young females undergoing neoadjuvant chemotherapy treatment for osteosarcoma.
01/2002	Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute.

Articles by Research Topic

Disease

27	Osteosarcoma (Osteogenic Sarcoma) 10/2007 - 01/2002
7	Neoplasms (Cancer) 02/2007 - 06/2003
4	Sarcoma (Soft Tissue Sarcoma) 02/2007 - 07/2003
3	Ewing's Sarcoma (Sarcoma, Ewing) 07/2006 - 01/2004
2	Neoplasm Metastasis (Metastasis) 12/2006 - 05/2004
1	Second Primary Neoplasms (Neoplasms, Second) 10/2005
1	Necrosis 09/2005
1	Vomiting 08/2003
1	Spontaneous Fractures (Pathological Fracture) 08/2003

Drug/Important Bio-Agent (IBA)

4	P-GlycoproteinIBA 10/2007 - 02/2003
4	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2007 - 08/2003
4	Methotrexate (Mexate)FDA LinkGeneric 04/2006 - 07/2003
3	Ifosfamide FDA LinkGeneric 06/2007 - 08/2003
2	Cisplatin (Platino)FDA LinkGeneric 12/2005 - 08/2003
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2004
1	Somatostatin Receptors (Somatostatin Receptor)IBA 10/2003
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2003
1	tropisetron (Navoban)IBA 08/2003
1	Alkaline PhosphataseIBA 01/2002

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 07/2007 - 01/2002
1	Adjuvant Chemotherapy 12/2006
1	Limb Salvage 08/2003
1	Amputation 08/2003